Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat

Samuel Monroe Cohen, Lora L Arnold, Eva Uzvolgyi, Martin Cano, Margaret St. John, Shinji Yamamoto, Xiufen Lu, X. Chris Le

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Dimethylarsinic acid (DMAV) is carcinogenic to the rat urinary bladder when administered at high doses in the diet or drinking water. At a dietary dose of 100 ppm (μg/g), it produces cytotoxicity within 6 h and increased proliferation (hyperplasia) by 7 days of administration. We hypothesize that formation of the reactive organic intermediate dimethylarsinous acid (DMAIII) is involved in the induction of the cytotoxicity. To evaluate the possibility that DMAV administration produces urothelial toxicity and regeneration by the formation of trivalent arsenicals, 2,3-dimercaptopropane-1-sulfonic acid (DMPS, 5600 ppm), a chelator of trivalent arsenicals, was co-administered with DMAV (100 ppm) for 2 weeks to groups of female Fischer F344 rats. Based on light and scanning electron microscopy, and bromodeoxyuridine labeling index, DMAV produced cytotoxicity and regenerative hyperplasia of the urothelium which was inhibited by co-administration with DMPS. The major forms of arsenic in the 24-h urine of rats administered DMAV were high concentrations of DMAV (66.4 ± 2.7 μM) itself and the pentavalent organic arsenical trimethylarsine oxide (TMAO) (73.2 ± 9.5 μM). Co-administration with DMPS led to an increase in DMAV (507 ± 31 μM) with a decrease in TMAO (2.8 ± 0.4 μM) excretion. The formation of TMAO from DMAV mechanistically suggests formation of the intermediate trivalent metabolite, DMAIII. In a second experiment evaluating fresh void urines collected on study days 1, 71, and 175, we detected DMAIII in the urine of DMAV and DMAV plus DMPS-treated rats at approximately micromolar concentrations. Using rat (MYP3) and human (1T1) urothelial cells, cytotoxicity for trivalent arsenicals, sodium arsenite, monomethylarsonous acid (MMAIII), and DMAIII was demonstrated at 0.4-4.8 μM concentrations, whereas MMAV, DMAV, and TMAO were cytotoxic at millimolar concentrations. The presence of DMAIII at micromolar concentrations in the urine of rats fed 100 ppm DMAV suggests that DMAIII produced in vivo may be involved in the toxic effects in the rat urinary bladder after dietary administration of DMAV.

Original languageEnglish (US)
Pages (from-to)1150-1157
Number of pages8
JournalChemical Research in Toxicology
Volume15
Issue number9
DOIs
StatePublished - Sep 1 2002

Fingerprint

Cacodylic Acid
Unithiol
Arsenicals
Toxicity
Rats
Regeneration
Cytotoxicity
Urine
Inbred F344 Rats
Hyperplasia
Urinary Bladder
Urothelium
Sulfonic Acids
Poisons
Arsenic
Bromodeoxyuridine
Chelating Agents
Drinking Water
Electron Scanning Microscopy
Nutrition

ASJC Scopus subject areas

  • Toxicology

Cite this

Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. / Cohen, Samuel Monroe; Arnold, Lora L; Uzvolgyi, Eva; Cano, Martin; St. John, Margaret; Yamamoto, Shinji; Lu, Xiufen; Le, X. Chris.

In: Chemical Research in Toxicology, Vol. 15, No. 9, 01.09.2002, p. 1150-1157.

Research output: Contribution to journalArticle

Cohen, Samuel Monroe ; Arnold, Lora L ; Uzvolgyi, Eva ; Cano, Martin ; St. John, Margaret ; Yamamoto, Shinji ; Lu, Xiufen ; Le, X. Chris. / Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. In: Chemical Research in Toxicology. 2002 ; Vol. 15, No. 9. pp. 1150-1157.
@article{fb1e6c18f08c4060826e3a4fd42937a0,
title = "Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat",
abstract = "Dimethylarsinic acid (DMAV) is carcinogenic to the rat urinary bladder when administered at high doses in the diet or drinking water. At a dietary dose of 100 ppm (μg/g), it produces cytotoxicity within 6 h and increased proliferation (hyperplasia) by 7 days of administration. We hypothesize that formation of the reactive organic intermediate dimethylarsinous acid (DMAIII) is involved in the induction of the cytotoxicity. To evaluate the possibility that DMAV administration produces urothelial toxicity and regeneration by the formation of trivalent arsenicals, 2,3-dimercaptopropane-1-sulfonic acid (DMPS, 5600 ppm), a chelator of trivalent arsenicals, was co-administered with DMAV (100 ppm) for 2 weeks to groups of female Fischer F344 rats. Based on light and scanning electron microscopy, and bromodeoxyuridine labeling index, DMAV produced cytotoxicity and regenerative hyperplasia of the urothelium which was inhibited by co-administration with DMPS. The major forms of arsenic in the 24-h urine of rats administered DMAV were high concentrations of DMAV (66.4 ± 2.7 μM) itself and the pentavalent organic arsenical trimethylarsine oxide (TMAO) (73.2 ± 9.5 μM). Co-administration with DMPS led to an increase in DMAV (507 ± 31 μM) with a decrease in TMAO (2.8 ± 0.4 μM) excretion. The formation of TMAO from DMAV mechanistically suggests formation of the intermediate trivalent metabolite, DMAIII. In a second experiment evaluating fresh void urines collected on study days 1, 71, and 175, we detected DMAIII in the urine of DMAV and DMAV plus DMPS-treated rats at approximately micromolar concentrations. Using rat (MYP3) and human (1T1) urothelial cells, cytotoxicity for trivalent arsenicals, sodium arsenite, monomethylarsonous acid (MMAIII), and DMAIII was demonstrated at 0.4-4.8 μM concentrations, whereas MMAV, DMAV, and TMAO were cytotoxic at millimolar concentrations. The presence of DMAIII at micromolar concentrations in the urine of rats fed 100 ppm DMAV suggests that DMAIII produced in vivo may be involved in the toxic effects in the rat urinary bladder after dietary administration of DMAV.",
author = "Cohen, {Samuel Monroe} and Arnold, {Lora L} and Eva Uzvolgyi and Martin Cano and {St. John}, Margaret and Shinji Yamamoto and Xiufen Lu and Le, {X. Chris}",
year = "2002",
month = "9",
day = "1",
doi = "10.1021/tx020026z",
language = "English (US)",
volume = "15",
pages = "1150--1157",
journal = "Chemical Research in Toxicology",
issn = "0893-228X",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat

AU - Cohen, Samuel Monroe

AU - Arnold, Lora L

AU - Uzvolgyi, Eva

AU - Cano, Martin

AU - St. John, Margaret

AU - Yamamoto, Shinji

AU - Lu, Xiufen

AU - Le, X. Chris

PY - 2002/9/1

Y1 - 2002/9/1

N2 - Dimethylarsinic acid (DMAV) is carcinogenic to the rat urinary bladder when administered at high doses in the diet or drinking water. At a dietary dose of 100 ppm (μg/g), it produces cytotoxicity within 6 h and increased proliferation (hyperplasia) by 7 days of administration. We hypothesize that formation of the reactive organic intermediate dimethylarsinous acid (DMAIII) is involved in the induction of the cytotoxicity. To evaluate the possibility that DMAV administration produces urothelial toxicity and regeneration by the formation of trivalent arsenicals, 2,3-dimercaptopropane-1-sulfonic acid (DMPS, 5600 ppm), a chelator of trivalent arsenicals, was co-administered with DMAV (100 ppm) for 2 weeks to groups of female Fischer F344 rats. Based on light and scanning electron microscopy, and bromodeoxyuridine labeling index, DMAV produced cytotoxicity and regenerative hyperplasia of the urothelium which was inhibited by co-administration with DMPS. The major forms of arsenic in the 24-h urine of rats administered DMAV were high concentrations of DMAV (66.4 ± 2.7 μM) itself and the pentavalent organic arsenical trimethylarsine oxide (TMAO) (73.2 ± 9.5 μM). Co-administration with DMPS led to an increase in DMAV (507 ± 31 μM) with a decrease in TMAO (2.8 ± 0.4 μM) excretion. The formation of TMAO from DMAV mechanistically suggests formation of the intermediate trivalent metabolite, DMAIII. In a second experiment evaluating fresh void urines collected on study days 1, 71, and 175, we detected DMAIII in the urine of DMAV and DMAV plus DMPS-treated rats at approximately micromolar concentrations. Using rat (MYP3) and human (1T1) urothelial cells, cytotoxicity for trivalent arsenicals, sodium arsenite, monomethylarsonous acid (MMAIII), and DMAIII was demonstrated at 0.4-4.8 μM concentrations, whereas MMAV, DMAV, and TMAO were cytotoxic at millimolar concentrations. The presence of DMAIII at micromolar concentrations in the urine of rats fed 100 ppm DMAV suggests that DMAIII produced in vivo may be involved in the toxic effects in the rat urinary bladder after dietary administration of DMAV.

AB - Dimethylarsinic acid (DMAV) is carcinogenic to the rat urinary bladder when administered at high doses in the diet or drinking water. At a dietary dose of 100 ppm (μg/g), it produces cytotoxicity within 6 h and increased proliferation (hyperplasia) by 7 days of administration. We hypothesize that formation of the reactive organic intermediate dimethylarsinous acid (DMAIII) is involved in the induction of the cytotoxicity. To evaluate the possibility that DMAV administration produces urothelial toxicity and regeneration by the formation of trivalent arsenicals, 2,3-dimercaptopropane-1-sulfonic acid (DMPS, 5600 ppm), a chelator of trivalent arsenicals, was co-administered with DMAV (100 ppm) for 2 weeks to groups of female Fischer F344 rats. Based on light and scanning electron microscopy, and bromodeoxyuridine labeling index, DMAV produced cytotoxicity and regenerative hyperplasia of the urothelium which was inhibited by co-administration with DMPS. The major forms of arsenic in the 24-h urine of rats administered DMAV were high concentrations of DMAV (66.4 ± 2.7 μM) itself and the pentavalent organic arsenical trimethylarsine oxide (TMAO) (73.2 ± 9.5 μM). Co-administration with DMPS led to an increase in DMAV (507 ± 31 μM) with a decrease in TMAO (2.8 ± 0.4 μM) excretion. The formation of TMAO from DMAV mechanistically suggests formation of the intermediate trivalent metabolite, DMAIII. In a second experiment evaluating fresh void urines collected on study days 1, 71, and 175, we detected DMAIII in the urine of DMAV and DMAV plus DMPS-treated rats at approximately micromolar concentrations. Using rat (MYP3) and human (1T1) urothelial cells, cytotoxicity for trivalent arsenicals, sodium arsenite, monomethylarsonous acid (MMAIII), and DMAIII was demonstrated at 0.4-4.8 μM concentrations, whereas MMAV, DMAV, and TMAO were cytotoxic at millimolar concentrations. The presence of DMAIII at micromolar concentrations in the urine of rats fed 100 ppm DMAV suggests that DMAIII produced in vivo may be involved in the toxic effects in the rat urinary bladder after dietary administration of DMAV.

UR - http://www.scopus.com/inward/record.url?scp=0036736824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036736824&partnerID=8YFLogxK

U2 - 10.1021/tx020026z

DO - 10.1021/tx020026z

M3 - Article

C2 - 12230408

AN - SCOPUS:0036736824

VL - 15

SP - 1150

EP - 1157

JO - Chemical Research in Toxicology

JF - Chemical Research in Toxicology

SN - 0893-228X

IS - 9

ER -